Clifford Chance has advised Marinomed Biotech AG on the company’s successful IPO. The company was listed on the official market (prime market segment) of the Vienna…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
